GE Healthcare has announced a $40 million investment in its manufacturing facility in Carrigtwohill, Cork.

The investment which is supported by the Department of Jobs, Enterprise and Innovation through IDA Ireland, will double the Carrigtwohill facility’s production capacity of medical imaging contrast media – from 22.5 million to 43 million units per year.

This significant investment will position GE Healthcare globally for growth in developing precision medicine and biopharmaceuticals.

Paschal McCarthy, Managing Director, Global Supply Chain at GE Healthcare said:
“Today’s announcement represents a key development in the journey of our facility here in Carrigtwohill. We are proud to be part of GE Healthcare’s Life Sciences division as it grows and positions itself to meet the international demand for precision medicine, biologics and other advanced medicines such as cell and immunotherapies. Most importantly, this investment in our facility represents a significant vote of confidence in our people and their commitment to delivering the very best possible products available in the market”.

Established in 1992, GE Healthcare’s Cork facility fills, packs, and distributes contrast media used in medical scans to aid the diagnosis of disease to more than 80 markets internationally.  Contrast media is commonly used during MRI scans and may be ingested by or injected into a patient in order to improve the visibility of the body’s internal structure. Today’s announcement builds on the development of a $10 million production suite at the Carrigtwohill facility in 2012 which saw the site’s manufacturing capacity increase by over fifty percent at that time.